Medpace Holdings, Inc. (NASDAQ:MEDP) Q3 2023 Earnings Call Transcript

Christine Rains: Great, thank you. And then not to dig too deep in the details, but it seems like you had a relative jump in your metabolic exposure. It sounds like it wasn’t just one larger study. So hoping you can give any color there.

Jesse Geiger: Yes, Christine, a couple of studies in the category have been burning really well. It’s – nothing to call out there other than this year, we’ve had good success in the space over the past couple of quarters and that’s continuing.

Christine Rains: Great. Thank you. That’s all for us.

Operator: Thank you. This will end the Q&A portion of today’s conference. I would now like to turn the conference back to Lauren Morris for closing remarks.

Lauren Morris: Thank you for joining us on today’s call and for your interest in Medpace. We look forward to speaking with you again on our fourth quarter 2023 earnings call.

Operator: This concludes today’s conference call. Thank you all for participating. You may now disconnect, and have a pleasant day.